{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:50:56Z","timestamp":1786996256738,"version":"build-2736575974"},"reference-count":119,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.rgmx.2019.11.003","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T07:54:44Z","timestamp":1582271684000},"page":"190-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Consenso mexicano sobre diagn\u00f3stico, prevenci\u00f3n y tratamiento de la gastropat\u00eda y enteropat\u00eda por antiinflamatorios no esteroideos"],"prefix":"10.1016","volume":"85","author":[{"given":"M.V.","family":"Bielsa-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Tamayo-de la Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Liz\u00e1rraga-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Remes-Troche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Carmona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Aldana-Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Avenda\u00f1o-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Ballesteros-Amozorrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Ari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"de Giau-Triulzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Flores-Rend\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Huerta-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hern\u00e1ndez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Murcio-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.O.","family":"J\u00e1quez-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Meixueiro-Daza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Nogueira-de Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rodr\u00edguez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Santoyo-Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Solorzano-Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.","family":"Uscanga-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zamarripa-Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2019.11.003_bib0600","first-page":"18","article-title":"Epidemiology of NSAID induced gastrointestinal complications","volume":"56","author":"Singh","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0605","doi-asserted-by":"crossref","unstructured":"Reguant-\u00c1lvarez, M. y Torrado-Fonseca, M. (2016). El m\u00e9todo Delphi. REIRE, Revista d\u2019Innovaci\u00f3 i Recerca en Educaci\u00f3, 9 (1), 87-102. DOI: 10.1344\/reire2016.9.1916","DOI":"10.1344\/reire2016.9.1916"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0610","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0615","first-page":"417","article-title":"El sistema GRADE para la clasificar del nivel de evidencia y el grado de recomendaciones en los informes de las gu\u00edas cl\u00ednicas","volume":"77","author":"O\u00f1ate-Oca\u00f1a","year":"2009","journal-title":"Cir Cir"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0620","unstructured":"Medicines uses and spending in the U.S. A review of 2016 and outlook to 2021. Report by the Quintiles IMS Institute. Estados Unidos: IQVIA Institute; 2017. Disponible en: https:\/\/www.iqvia.com\/institute\/reports\/medicines-use-and-spending-in-the-us-a-review-of-2016."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0625","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2005.08.003","article-title":"National adherence to evidence-based guidelines for the prescription of nonsteroidal antiinflammatory drugs","volume":"129","author":"Abraham","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0630","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-170706","article-title":"Alzheimer's disease can be spared by nonsteroidal anti-inflammatory drugs","volume":"62","author":"McGeer","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0635","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd1034","article-title":"The development of COX2 inhibitors","volume":"2","author":"Flower","year":"2003","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0640","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: Clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato","year":"2010","journal-title":"Gastroenterol Clin North Am."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0645","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0650","doi-asserted-by":"crossref","first-page":"258209","DOI":"10.1155\/2013\/258209","article-title":"Current perspectives in NSAID-induced gastropathy","volume":"2013","author":"Sinha","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0655","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","article-title":"Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: A cross-sectional capsule enteroscopy study","volume":"5","author":"Maiden","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0660","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5946\/ce.2012.45.2.138","article-title":"Non-Steroidal Anti-Inflammatory drug-Induced enteropathy","volume":"45","author":"Lim","year":"2012","journal-title":"Clin Endosc"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0665","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5217\/ir.2017.15.4.446","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy","volume":"15","author":"Sung","year":"2017","journal-title":"Intest Res"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0670","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1476-5381.2011.01509.x","article-title":"NSAID gastropathy and enteropathy: Distinct pathogenesis likely necessitates distinct prevention strategies","volume":"165","author":"Wallace","year":"2012","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0675","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 Expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0680","doi-asserted-by":"crossref","first-page":"91","DOI":"10.18773\/austprescr.2017.037","article-title":"Peptic ulcer disease and non-steroidal anti-inflammatory drugs","volume":"40","author":"Musa","year":"2017","journal-title":"Aust Prescr."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0685","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","article-title":"Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract","volume":"24","author":"Sostres","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0690","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2036.2004.02297.x","article-title":"Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection","volume":"21","author":"P\u00e9rez-Aisa","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0695","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gastrohep.2013.11.014","article-title":"Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document elaborated by nominated experts of three scientific associations (SER-SEC-AEG)","volume":"37","author":"Lanas","year":"2014","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0700","unstructured":"U.S. Food and Drug Administration. Medication Guide for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Silver Spring: FDA; 2007. Disponible en: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/ucm089162.pdf."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0705","unstructured":"European Medicines Agency. European Medicines Agency review concludes positive benefit-risk balance for non-selective NSAIDs. Londres: EMA; 2006."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0710","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3748\/wjg.v19.i12.1861","article-title":"Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy","volume":"19","author":"Wallace","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"Suppl 3","key":"10.1016\/j.rgmx.2019.11.003_bib0715","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4175","article-title":"Nonsteroidal- anti-nflammatory drugs and upper and lower gastrointestinal mucosal damage","volume":"15","author":"Sostres","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0720","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/pgmj.2005.039586","article-title":"Is non-steroidal anti-inflammatory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?","volume":"82","author":"Adebayo","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0725","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3164\/jcbn.13-84","article-title":"The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium","volume":"54","author":"Handa","year":"2014","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0730","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5946\/ce.2012.45.2.138","article-title":"Non-steroidal Anti-Inflammatory drug-induced enteropathy","volume":"45","author":"Lim","year":"2012","journal-title":"Clin Endosc"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0735","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","article-title":"Meta-analysis: Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users","volume":"21","author":"Vergara","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0740","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2014.06.021","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: A systematic review and meta-analysis","volume":"13","author":"Jiang","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0745","first-page":"73","article-title":"NSAID and gastrointestinal risk","volume":"48","author":"Marc\u00e9na","year":"2016","journal-title":"Aten Primaria."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0750","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","article-title":"Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding","volume":"62","author":"Mass\u00f3 Gonz\u00e1lez","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0755","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/00005344-200605001-00011","article-title":"GI risk and risk factors of NSAIDs","volume":"47","author":"Laine","year":"2006","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0760","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/07853890902887295","article-title":"Myths and facts in the use of anti-inflammatory drugs","volume":"41","author":"Hunt","year":"2009","journal-title":"Ann Med."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0765","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2006.11.012","article-title":"Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial","volume":"132","author":"Lanas","year":"2007","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0770","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0775","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0780","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0785","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMe068061","article-title":"The charisma of subgroups and the subgroups of CHARISMA","volume":"354","author":"Pfeffer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0790","first-page":"325","article-title":"The fourth Mexican consensus on Helicobacter pylori","volume":"83","author":"Bosques-Padilla","year":"2018","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0795","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2014.82","article-title":"Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: A systematic review and meta-analysis","volume":"109","author":"Anglin","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0800","first-page":"1153","article-title":"Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic steroidal anti-inflammatory drug use","volume":"82","author":"Larkai","year":"1987","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0805","doi-asserted-by":"crossref","first-page":"116","DOI":"10.24871\/1722016116-123","article-title":"Diagnosis and management of gastroenteropathy associated to non-steroidal anti-inflammatory drugs","volume":"17","author":"Ilone","year":"2016","journal-title":"The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0810","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/ar4134","article-title":"Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: Meta-analysis of 51,000 patients enrolled in 52 randomized trials","volume":"15","author":"Moore","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0815","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation. an overview of epidemiologic studies published in the 1990s","volume":"160","author":"Hernandez-Diaz","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-1-1","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations","volume":"1","author":"de Abajo","year":"2001","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0825","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/ajg.2009.164","article-title":"Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice","volume":"104","author":"Lanas","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0830","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1572-0241.2005.41833.x","article-title":"A Nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use","volume":"100","author":"Lanas","year":"2005","journal-title":"Am J Gastrooenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0835","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/rheumatology\/keq058","article-title":"A review of the gastrointestinal safety data\u2014a gastroenterologist's perspective","volume":"49","author":"Lanas","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0840","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000089789","article-title":"Microbial flora in NSAID-induced intestinal damage: A role for antibiotics?","volume":"73","author":"Lanas","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0845","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dld.2012.12.005","article-title":"Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage","volume":"45","author":"Watanabe","year":"2013","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0850","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1542-3565(04)00603-2","article-title":"Visible small-intestinal mucosal injury in chronic NSAID users","volume":"3","author":"Graham","year":"2005","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0855","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000190403","article-title":"Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: Effects of antirheumatoid arthritis drugs","volume":"78","author":"Sugimori","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0860","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00535-009-0040-z","article-title":"Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: The experience of two medical centers in capsule endoscopy","volume":"44","author":"Endo","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0865","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/00365520701794121","article-title":"Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double balloon endoscopy: A Japanese multicenter study","volume":"43","author":"Matsumoto","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0870","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2036.2006.03043.x","article-title":"Systematic review: The lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs","volume":"24","author":"Laine","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0875","doi-asserted-by":"crossref","first-page":"e8090","DOI":"10.1097\/MD.0000000000008090","article-title":"Analysis of risk factors for colonic diverticular bleeding and recurrence","volume":"96","author":"Taki","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0880","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-3565(05)00980-8","article-title":"Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease","author":"Takeuchi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0885","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: A case-control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0890","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1572-0241.2000.02263.x","article-title":"Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease","volume":"95","author":"Bonner","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0895","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","article-title":"An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia","volume":"17","author":"Reinisch","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0900","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/apt.14606","article-title":"Systematic review with meta-analysis: Association between acetaminophen and nonsteroidal anti-inflammatory drugs(NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation","volume":"47","author":"Moninuola","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0905","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-008-2182-9","article-title":"A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding","volume":"43","author":"Kameda","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0910","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1067\/mge.2001.112181","article-title":"Total enteroscopy with a nonsurgical steerable double balloon method","volume":"53","author":"Yamamoto","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0915","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3748\/wjg.v11.i31.4861","article-title":"Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy","volume":"11","author":"Hayashi","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0920","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00535-008-2248-8","article-title":"Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy","volume":"19","author":"Maiden","year":"2009","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-008-2292-4","article-title":"Double-balloon endoscopy: Past, present, and future","volume":"44","author":"Sunada","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0930","first-page":"309","article-title":"Mexican consensus on dyspepsia","volume":"82","author":"Carmona-S\u00e1nchez","year":"2017","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0935","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gie.2015.04.003","article-title":"The role of endoscopy in dyspepsia","volume":"82","author":"Shaukat","year":"2015","journal-title":"Gastrointest Endosc."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0940","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.28.7.869","article-title":"Preoperative and intraoperative localisation of gastrointestinal bleeding of obscure origin","volume":"28","author":"Lau","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0945","first-page":"419","article-title":"Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: A population-based study","volume":"92","author":"Longstreth","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0950","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cgh.2008.01.005","article-title":"Double-balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small-bowel disease: A meta-analysis","volume":"6","author":"Pasha","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0955","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ajg.2015.246","article-title":"ACG clinical guideline: Diagnosis and management of small bowel bleeding","volume":"110","author":"Gerson","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0960","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1756283X13513995","article-title":"Small bowel stricture characterization and outcomes of dilatation by double-balloon enteroscopy: A single-centre experience","volume":"7","author":"Gill","year":"2014","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0965","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.3748\/wjg.v23.i45.8073","article-title":"Double-balloon enteroscopy-assisted dilatation avoids surgery for small bowel strictures: A systematic review","volume":"23","author":"Baars","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0970","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(84)92739-9","article-title":"Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal anti-inflammatory drugs","volume":"2","author":"Bjarnason","year":"1984","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0975","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2036.1998.00300.x","article-title":"Review article: Non-steroidal anti-inflammatory drug-induced gastrointestinal permeability","volume":"12","author":"Davies","year":"1998","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0980","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14712\/18059694.2016.56","article-title":"Non-steroidal anti-inflammatory drug induced injury to the small intestine","volume":"53","author":"Tachec\u00ed","year":"2010","journal-title":"Acta Medica (Hradec Kralove)."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0985","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib0990","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","article-title":"Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: A randomised comparison","volume":"368","author":"Cannon","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2019.11.003_bib0995","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2011.580340","article-title":"Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: Two randomized trials","volume":"27","author":"Hochberg","year":"2011","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1000","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","article-title":"Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): A randomised trial","volume":"376","author":"Chan","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2006.07.069","article-title":"Risk of cardiovascular events in patients receiving celecoxib: A meta-analysis of randomized clinical trials","volume":"99","author":"White","year":"2007","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1010","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.108.764530","article-title":"Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: The cross trial safety analysis","volume":"117","author":"Solomon","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3111\/13696998.2012.659778","article-title":"The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial","volume":"15","author":"Brereton","year":"2012","journal-title":"J Med Econ."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/03007995.2017.1281110","article-title":"Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: A systematic review","volume":"33","author":"Yang","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1030","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Eng J Med."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: Results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000075926","article-title":"Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients","volume":"68","author":"Stupnicki","year":"2003","journal-title":"Digestion."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1050","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(00)85703-0","article-title":"A randomized study of omeprazole compared to misoprostol for prevention of recurrent ulcers and ulcer hemorrhage in high risk patients ingesting aspirin or NSAIDs","volume":"118","author":"Jensen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1055","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1200\/JCO.1995.13.10.2637","article-title":"Nonsteroidal antiinflammatory drugs for cancer pain: Comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage","volume":"13","author":"Valentini","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-123-5-199509010-00004","article-title":"Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: A comparison of three regimens","volume":"123","author":"Raskin","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1065","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1070","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/apt.13642","article-title":"Systematic review with network meta-analysis: Comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity","volume":"43","author":"Yuan","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2012.467","article-title":"GI-REASONS: A novel 6-month, prospective, randomized, open- label, blinded endpoint (PROBE) trial","volume":"108","author":"Cryer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1080","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/ar4134","article-title":"Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: Meta-analysis of 51,000 patients enrolled in 52 randomized trials","volume":"15","author":"Moore","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1085","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"y cols. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"Capone","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1090","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(11)60354-5","article-title":"Proton pump inhibitors and low-dose aspirin markedly exacerbate NSAID-induced small intestinal injury: A link to dysbiosis?","volume":"140","author":"Wallace","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","article-title":"Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo","volume":"3","author":"Goldstein","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1100","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","article-title":"A quantitative analysis of NSAID-induced small bowel pathology by capsule endoscopy","volume":"128","author":"Maiden","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2362.2010.02290.x","article-title":"Distribution of small intestinal mucosal injuries as a result of NSAID administration","volume":"40","author":"Fujimora","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1110","first-page":"728","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with nonsteroidal anti-inflammatory drugs: A randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2036.2003.01528.x","article-title":"Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: A double-blind, placebo-controlled trial","volume":"17","author":"Lai","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1523-5378.2007.00543.x","article-title":"Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: Double-blind, randomized, placebo-controlled trial","volume":"12","author":"De Leest","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmx.2019.11.003_bib1140","doi-asserted-by":"crossref","first-page":"G506","DOI":"10.1152\/ajpgi.90553.2008","article-title":"Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: Involvement of lactic acid","volume":"297","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2010.04324.x","article-title":"Clinical trial: The effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy: A randomized, double-blind, cross-over, placebo-controlled study","volume":"32","author":"Montalto","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3164\/jcbn.40.148","article-title":"Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: A randomized, multicenter, controlled trial - STORM STUDY","volume":"40","author":"Park","year":"2007","journal-title":"J Clin Biochem Nutr."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1155","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00535-007-2076-2","article-title":"Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: A randomized, double-blind, placebo-controlled trial","volume":"42","author":"Terano","year":"2007","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1160","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-006-9367-y","article-title":"Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers","volume":"52","author":"Kim","year":"2007","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1165","first-page":"237","article-title":"Small intestinal ulcers and intestinal flora in rats given indomethacin","volume":"54","author":"Kent","year":"1969","journal-title":"Am J Pathol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/1071576042000209808","article-title":"Mechanism of hydroxyl radical scavenging by rebamipide: Identification of mono-hydroxylated rebamipide as a major reaction product","volume":"38","author":"Sakurai","year":"2004","journal-title":"Free Radic Res."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1175","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1007\/s10620-008-0255-5","article-title":"An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors","volume":"53","author":"Chitapanarux","year":"2008","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1180","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3748\/wjg.v17.i46.5117","article-title":"Aspirin-induced small bowel injuries and the preventive effect of rebamipide","volume":"17","author":"Mizukami","year":"2011","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00535-013-0805-2","article-title":"A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and\/or non-steroidal anti-inflammatory drug induced small bowel injury","volume":"49","author":"Kurokawa","year":"2014","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rgmx.2019.11.003_bib1190","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1053\/j.gastro.2008.07.067","article-title":"Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti- inflammatory drug diclofenac","volume":"135","author":"Laine","year":"2008","journal-title":"Gastroenterology."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090620300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090620300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:47:40Z","timestamp":1759812460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090620300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0375090620300033"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2019.11.003","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consenso mexicano sobre diagn\u00f3stico, prevenci\u00f3n y tratamiento de la gastropat\u00eda y enteropat\u00eda por antiinflamatorios no esteroideos","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}